ACHIEVEMENTS AND PROSPECTS OF SCIENTIFIC RESEARCH: COVID-19 INFECTION

Abstract

The pandemic of Corona Virus Disease 2019 infection, caused by severe acute respiratory syndrome coronavirus, has posed a significant threat to global health. We are now witnessing an unsurpassed increase in the number of clinical trials worldwide. Old and new drugs are tested in clinical trials as potential treatments either for their direct anti-viral activity or for their ability to induce effects on respiratory and cardiovascular symptoms and complications specific to Corona Virus. Despite the law trends of Corona Virus, large-scale studies have not proven significant effectiveness in the clinical treatment of patients with coronavirus 2019. Such a strategy is likely to give rise to a range of safety and efficacy challenges that could be addressed through preliminary pharmaco-genetic studies to identify the risk groups for personification of therapy approach. Addressing the personification of drug treatment Corona Virus Disease 2019 becomes an urgent need to interpret the conflicting results of clinical trials and establish the apparent efficacy of any particular drug.